Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.72T | 5.88T | 6.06T | 4.70T | 4.63T | 5.02T | Gross Profit |
8.95T | 10.70T | 6.06T | 4.70T | 4.63T | 5.02T | EBIT |
1.79T | 0.00 | 3.86T | 1.96T | 962.09B | 749.05B | EBITDA |
7.04T | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
1.49T | 1.49T | 1.12T | 1.13T | 777.02B | 528.15B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.10T | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Assets |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Debt |
0.00 | 25.75T | 47.28T | 19.11T | 18.09T | 44.91T | Net Debt |
-12.10T | -84.13T | -66.35T | -91.65T | -84.89T | -33.42T | Total Liabilities |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Stockholders Equity |
10.55T | 19.59T | 17.23T | 17.02T | 16.80T | 15.99T |
Cash Flow | Free Cash Flow | ||||
0.00 | -10.31T | 13.03T | 9.25T | 34.51T | 7.61T | Operating Cash Flow |
0.00 | -9.84T | 13.43T | 9.64T | 34.90T | 8.06T | Investing Cash Flow |
0.00 | -1.27T | -10.68T | -2.20T | -10.14T | -3.37T | Financing Cash Flow |
0.00 | 8.31B | -977.14B | -875.97B | -436.07B | -251.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $171.96B | 7.99 | 13.74% | 6.57% | 6.79% | 8.57% | |
78 Outperform | $83.45B | 9.80 | 8.86% | 2.56% | 8.69% | 50.61% | |
76 Outperform | $96.22B | 7.71 | 13.16% | 2.33% | 6.56% | 19.02% | |
70 Outperform | $129.66B | 10.59 | 9.70% | 3.06% | 13.21% | -12.06% | |
68 Neutral | $204.11B | 11.23 | 11.05% | 2.48% | 3.22% | 16.51% | |
65 Neutral | $116.02B | 10.37 | 6.04% | 3.58% | 8.20% | 49.26% | |
64 Neutral | $13.34B | 9.25 | 9.42% | 4.85% | 16.07% | -8.44% |